Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

1.1K
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
1.1K
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

419
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
419
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

1.1K
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
1.1K
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

522
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
522
Peptic Ulcer Disease V: Surgical Management and Nursing Care01:25

Peptic Ulcer Disease V: Surgical Management and Nursing Care

798
Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
798
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

1.1K
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Breast Cancer Outcomes From Ductal Carcinoma In Situ: A Population-Based Cohort Study.

International journal of cancer·2026
Same author

An implementation study of text invitation, mailed at-home human papillomavirus (HPV) self-testing and telehealth management in Aotearoa New Zealand, with a nested randomised controlled trial that compared offering an incentive vs. no offer with a repeat test kit.

BMC public health·2026
Same author

Endoscopic Pilonidal Sinus Treatment Versus Excisional Surgery: A Retrospective Comparison at an Australian Tertiary Centre.

ANZ journal of surgery·2026
Same author

Demographic profile of potential target populations in community laboratory and emergency department settings for consideration in expanding hepatitis C screening in Aotearoa New Zealand.

Journal of primary health care·2026
Same author

Quality of human resources staff ethnicity data in health in Aotearoa New Zealand: an audit of "not stated" staff ethnicity and a data linkage assessment.

The New Zealand medical journal·2026
Same author

Clinician and patient experiences with opportunistic offer of HPV self-testing in Aotearoa New Zealand primary care clinics: interview and survey findings.

BMC primary care·2026

Related Experiment Video

Updated: Jan 11, 2026

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
05:23

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance

Published on: March 7, 2025

725

Management of Helicobacter pylori Infection: Myanmar Consensus Report.

Than Than Aye1, Nwe Ni2, Tin Tin May1

  • 1Department of Gastroenterology, Yangon General Hospital, University of Medicine 1, Yangon, Myanmar.

Helicobacter
|November 14, 2025
PubMed
Summary

Myanmar developed its first consensus guideline for Helicobacter pylori (H. pylori) infection management. This guideline addresses testing and treatment strategies to combat rising drug resistance and improve H. pylori eradication rates.

Keywords:
Helicobacter pyloriMyanmardiagnosisguidelinesmanagement

More Related Videos

Author Spotlight: Detection and Treatment of Helicobacter pylori Infection
06:40

Author Spotlight: Detection and Treatment of Helicobacter pylori Infection

Published on: July 28, 2023

4.3K
Detection of Helicobacter pylori Infection and Antibiotic Resistance via Stool Quantitative Polymerase Chain Reaction Analysis
04:56

Detection of Helicobacter pylori Infection and Antibiotic Resistance via Stool Quantitative Polymerase Chain Reaction Analysis

Published on: May 16, 2025

1.1K

Related Experiment Videos

Last Updated: Jan 11, 2026

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
05:23

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance

Published on: March 7, 2025

725
Author Spotlight: Detection and Treatment of Helicobacter pylori Infection
06:40

Author Spotlight: Detection and Treatment of Helicobacter pylori Infection

Published on: July 28, 2023

4.3K
Detection of Helicobacter pylori Infection and Antibiotic Resistance via Stool Quantitative Polymerase Chain Reaction Analysis
04:56

Detection of Helicobacter pylori Infection and Antibiotic Resistance via Stool Quantitative Polymerase Chain Reaction Analysis

Published on: May 16, 2025

1.1K

Area of Science:

  • Gastroenterology
  • Infectious Diseases
  • Public Health

Background:

  • Helicobacter pylori (H. pylori) infection is prevalent in Myanmar, leading to significant complications like peptic ulcer bleeding and gastric cancer.
  • Myanmar faces an intermediate risk of gastric cancer, underscoring the need for effective H. pylori management.
  • Increasing antibiotic resistance, particularly to triple therapy, necessitates a standardized management guideline for H. pylori in Myanmar.

Purpose of the Study:

  • To establish the first consensus guideline for the clinical practice of Helicobacter pylori (H. pylori) infection management in Myanmar.
  • To provide evidence-based recommendations for diagnosing and treating H. pylori, considering local clinical practice and available evidence.
  • To address the growing challenge of antibiotic resistance in H. pylori treatment.

Main Methods:

  • A consensus group of 39 gastroenterologists and clinicians from the Myanmar GI & Liver Society (MGLS) was formed.
  • The Delphi method was employed in integrated meetings to develop consensus statements on H. pylori management.
  • Recommendations followed the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) system, with ≥80% agreement required for consensus.

Main Results:

  • Consensus was reached on 26 statements covering key aspects of H. pylori management: whom to test, how to test, whom to treat, and how to treat.
  • The guideline emphasizes post-treatment confirmation of H. pylori status to ensure successful eradication.
  • Recommendations were based on global literature and guidelines, with specific attention to evidence from Myanmar, due to limited local high-quality data.

Conclusions:

  • This consensus guideline provides a crucial framework for the proper diagnosis and treatment of H. pylori infection in Myanmar.
  • Effective H. pylori eradication is vital to prevent the further development of antibiotic resistance.
  • Future research should focus on third-line treatment regimens and the development of antibiotic sensitivity testing for H. pylori.